Frontiers in Nutrition · Nov 19, 2026
Low Serum Magnesium and Long-Term Mortality in Adults With Prior Metabolic and Bariatric Surgery: A Multicenter Propensity Score–Matched Cohort Study
By I-Chia Teng, Wei-Ting Wang, Ping-Hsun Feng
Background: Postoperative micronutrient disturbances are common after metabolic and bariatric surgery (MBS), but the long-term prognostic significance of hypomagnesemia remains unclear despite the overall cardiometabolic benefits of surgery. We evaluated whether low magnesium status was associated with subsequent all-cause mortality and cardiovascular outcomes after MBS. Methods: We conducted a retrospective multicenter cohort study using the TriNetX Global Collaborative Network. Adults with prior MBS and a qualifying magnesium measurement between 2010 and 2023 were classified as having low magnesium (<1.8 mg/dL) or normal magnesium (1.8–2.2 mg/dL). Outcomes were assessed from day 90 through 3 years after the index measurement, with extended follow-up of up to 5 years. The primary outcome was all-cause mortality; secondary outcomes were acute myocardial infarction, cerebral infarction, and atrial fibrillation/flutter. Propensity score matching was performed 1:1, yielding 8,238 patients per group. Cox proportional-hazards models estimated hazard ratios (HRs) with 95% confidence intervals (CIs). Results: From day 90 through 3 years after index, all-cause mortality occurred in 164 patients (1.99%) with low magnesium and 124 (1.51%) with normal magnesium. Low magnesium was associated with higher mortality (HR 1.34, 95% CI 1.06–1.69) and higher hazards of acute myocardial infarction (HR 1.77, 95% CI 1.24–2.53), cerebral infarction (HR 1.40, 95% CI 1.05–1.86), and atrial fibrillation/flutter (HR 1.82, 95% CI 1.44–2.30). No statistically significant association was observed for the negative-control outcome, acute appendicitis. The mortality association persisted over up to 5 years of follow-up (HR 1.40, 95% CI 1.16–1.70) and across all sensitivity analyses, while no significant subgroup heterogeneity was detected. Conclusion: Low magnesium was associated with higher long-term all-cause mortality after MBS, with secondary associations observed for several cardiovascular outcomes. Hypomagnesemia may be a clinically accessible marker of poorer prognosis, but prospective studies are needed to determine whether correction improves clinical outcomes.